Researchers at Massachusetts General Hospital found that the presence of cortical amyloid, measured by PET imaging, influenced the tie between increasing depression symptoms and cognitive decline among cognitively healthy older adults over a period of two to seven years. The findings in JAMA Network Open also showed that brain metabolism and hippocampal volume may also influence the link between depression symptoms and cognitive decline.